Markets:

Overview

News

Currencies

International

Treasuries

SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

0.6500 -0.0300 (-4.41%)

Streaming Delayed Price Updated: 3:01 PM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SciSparc Ltd. - Ordinary Shares

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

SciSparc Issued Israeli Patent For Its Core Technology For Treating Central Nervous Systems Disorders ↗

May 17, 2022

Patent extends protection for SciSparc’s novel compounds and methods already granted in the US, Australia and Japan

Via Benzinga

Has Clearmind Developed A Psychedelics-Based Drug That Can Treat Alcoholism? The FDA Is Interested ↗

May 13, 2022

On Wednesday, May 18, Clearmind Medicine Inc. (OTC Pink: CMNDF) will meet with the Center for Drug Evaluation and Research (CDER), a department within the FDA.

Via Benzinga

23 Stocks Moving in Friday's Pre-Market Session ↗

May 13, 2022

Gainers OTR Acquisition Corp. (NASDAQ: OTRA) rose 88.7% to $18.21 in pre-market trading after filing on Thursday showed shareholders approved merger with Comera Life Sciences.

Via Benzinga

The Hidden Potential Of The Endocannabinoid System? SciSparc Says Its Portfolio Of Cannabinoids-Derived Drug Candidates Tap The Body's Natural System ↗

May 12, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Originally motivated by a belief in the dangerous effects...

Via Benzinga

SciSparc Files Annual Report For Year Ended December 31, 2021 And Provides Corporate Update ↗

May 02, 2022

TEL AVIV, Israel, May 2, 2022 /PRNewswire/ -- SciSparc Ltd.

Via Benzinga

90 Biggest Movers From Yesterday ↗

May 13, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...

Via Benzinga

SciSparc And Clearmind Reveal Potential To Reduce Alcohol Consumption With Psychedelic Treatment In New Patent Application ↗

May 11, 2022

Image by Thom Masat on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Via Benzinga

SciSparc And Clearmind Medicine Inc. Collaboration Yields New Patent Application For Psychedelic Combination Treatment For Binge Behaviors ↗

May 10, 2022

Preclinical study results demonstrated the combination of SciSparc's CannAmide™ with Clearmind's MEAI has the potential to reduce alcohol consumption

Via Benzinga

55 Biggest Movers From Friday ↗

April 25, 2022

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate...

Via Benzinga

50 Biggest Movers From Yesterday ↗

March 29, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in...

Via Benzinga

12 Stocks Halted On A Circuit Breaker This Week ↗

March 25, 2022

A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore, and...

Via Benzinga

36 Stocks Moving In Friday's Mid-Day Session ↗

March 25, 2022

Gainers Forge Global Holdings, Inc. (NYSE: FRGE) shares jumped 66.4% to $20.70. Clever Leaves Holdings Inc. (NASDAQ: CLVR) jumped 29.1% to $2.04 after the company reported...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; US Pending Home Sales Index Drop 4.1% ↗

March 25, 2022

U.S. stocks traded opened on a mixed note this morning, with the Dow Jones gaining around 80 points on Friday. Following the market opening, the Dow traded up 0.25% to 34,795.46...

Via Benzinga

Alcoholism & Psychedelics: Clearmind Trials Reveal Certain Psychedelics Help Reduce Alcohol Consumption In Mice ↗

March 17, 2022

Clearmind Medicine Inc.

Via Benzinga

Clearmind Medicine, SciSparc Launch A Psychedelic Pharma Collaboration ↗

March 08, 2022

Psychedelic-focused biotech company Clearmind Medicine Inc. (CSE:CMND) (OTC: CMNDF) has signed a collaboration agreement with ...

Via Benzinga

Meet a Company Harnessnessing the Power of Synergy for its Drug Therapeutics ↗

January 20, 2022

Photo by Roberto Sorin on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice....

Via Benzinga

SciSparc Has Been Granted The Patent in the United States for its Core Technology, Used to Treat Central Nervous System Disorders.

January 06, 2022

Via AB Newswire

Topics Intellectual Property

68 Biggest Movers From Yesterday ↗

March 03, 2022

Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to...

Via Benzinga

Advances for Tourette Syndrome, Alzheimer’s Disease, Pain Management, Autism Spectrum Disorder and Epilepsy from Proprietary Compounds: SciSparc Ltd. (NASDAQ: SPRC)

January 05, 2022

Via Get News

Advances for Tourette Syndrome, Alzheimer's Disease, Pain Management, Autism Spectrum Disorder and Epilepsy from Proprietary Compounds: SciSparc Ltd. (NASDAQ: SPRC) SPRC Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems

January 05, 2022

Via Viz Release

Topics Intellectual Property

Pharmaceutical company SciSparc Ltd to make progress in treating nervous system disorders in 2022

January 04, 2022

Via AB Newswire

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.